Abstract
hPYY(3-36) injections have shown positive effects on appetite regulations, sparking increased interest in hPYY(3-36) research. Of great interest is oral delivery of hPYY(3-36) that can achieve clinically relevant weight-loss outcomes in what would be a highly patient compliant route. Successful oral delivery of other peptides utilizing the vitamin B 12 pathway has been shown but below clinically relevant levels. Herein, we present clinically relevant in vivo oral delivery of B 12-hPYY(3-36) conjugates.
Original language | English (US) |
---|---|
Pages (from-to) | 8707-8711 |
Number of pages | 5 |
Journal | Journal of Medicinal Chemistry |
Volume | 54 |
Issue number | 24 |
DOIs | |
State | Published - Dec 22 2011 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery